Close Menu

NEW YORK (360Dx) – Modest increases in some Medicare clinical lab testing prices for 2018 will take the edge off the final price cuts for laboratory tests stemming from the Protecting Access to Medicare Act in its first year, but will cut more strongly into profits in 2019 and 2020, Quest Diagnostics said on a conference call on Tuesday.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.